CUMYL-THPINACA
![]() | |
Systematic (IUPAC) name | |
---|---|
N-(1-Methyl-1-phenylethyl)-1-(tetrahydro-2H-pyran-4-yl)methyl-1H-indazole-3-carboxamide | |
Clinical data | |
Legal status |
|
Identifiers | |
CAS Number | 1400742-50-8 |
PubChem | CID 86273679 |
Chemical data | |
Formula | C23H27N3O2 |
Molar mass | 377.5 g/mol |
| |
|
CUMYL-THPINACA (also known as SGT-42) is an indazole-3-carboxamide based synthetic cannabinoid.[1] CUMYL-THPINACA acts as a potent agonist for the cannabinoid receptors, with approximately 6x selectivity for CB1, having an EC50 of 0.1nM for human CB1 receptors and 0.59nM for human CB2 receptors.[2]
Legal status
Sweden's public health agency suggested to classify CUMYL-THPINACA as hazardous substance on November 10, 2014.[3]
As of October 2015 CUMYL-THPINACA is a controlled substance in China.[4]
See also
References
- ↑ "CUMYL-THPINACA". Cayman Chemical. Retrieved 11 July 2015.
- ↑ Bowden; et al. (11 April 2013). "Patent WO 2014167530 - Cannabinoid compounds". New Zealand Patent application 623626. Retrieved 11 July 2015.
- ↑ "Cannabinoider föreslås bli klassade som hälsofarlig vara". Retrieved 11 July 2015.
- ↑ "关于å°å‘《éžè¯ç”¨ç±»éº»é†‰è¯å“和精神è¯å“列管办法》的通知" (in Chinese). China Food and Drug Administration. 27 September 2015. Retrieved 1 October 2015.
|
This article is issued from Wikipedia - version of the Saturday, April 02, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.